A Retrospective Analysis of Altitude Illness at the Himalayan Rescue Association Aid Post Manang (2018-2023).

IF 1.4 4区 医学 Q4 BIOPHYSICS
Suraj Shrestha, Sanjeev Kharel, Suman Acharya, Gobi Basyal, Sanjeeb S Bhandari
{"title":"A Retrospective Analysis of Altitude Illness at the Himalayan Rescue Association Aid Post Manang (2018-2023).","authors":"Suraj Shrestha, Sanjeev Kharel, Suman Acharya, Gobi Basyal, Sanjeeb S Bhandari","doi":"10.1177/15578682251376256","DOIUrl":null,"url":null,"abstract":"<p><p>Shrestha, Suraj, Sanjeev Kharel, Suman Acharya, Gobi Basyal, and Sanjeeb S. Bhandari. A Retrospective Analysis of Altitude Illness at the Himalayan Rescue Association Aid Post Manang (2018-2023). <i>High Alt Med Biol.</i> 00:00-00, 2025. <b><i>Introduction:</i></b> The Himalayan Rescue Association (HRA) in Nepal has been operating high-altitude aid posts in the Himalayas to alleviate illnesses in hikers and locals with a focus on acute mountain sickness (AMS), high-altitude pulmonary edema (HAPE), and high-altitude cerebral edema (HACE), as well as other common medical problems. This study examines the altitude-related illnesses occurring between 2018 and 2023 at the HRA Manang aid post. <b><i>Materials and Methods:</i></b> A retrospective study analyzing the medical records of HRA Manang from 2018 to 2023 was conducted. Demographics and diagnoses were documented, and the Lake Louise Score (LLS) was calculated for AMS cases. The frequency of altitude-related illness was compared among trekkers with/without a good ascent profile. <b><i>Results:</i></b> During the study period, a total of 2,904 people visited the aid post, with 337 (11.6%) suffering from altitude-related illnesses, including 274 AMS, 40 HAPE, 11 HACE, and 12 concurrent HAPE with HACE, with 58.8% of cases seen in the fall season. Most were adults, non-Nepali (70.3%), of which only 4.5% comprised the pediatric population. The majority of AMS cases were mild (70.6%) (LLS ≤5), while 17.2% had moderate to severe AMS. Almost one-third (28.2%) of cases had rapid ascent (elevation >500/day above 2,500 m), with a majority of 67.4% being Nepali compared to non-Nepali (<i>p</i> < 0.05). The proportion of HACE and concurrent HAPE with HACE was significantly higher among those with rapid ascent profiles. About 36.20% of cases with altitude-related illness had taken prophylactic acetazolamide, which was considerably lower among Nepali patients (<i>p</i> < 0.001). Motor vehicle evacuation (86.7%), followed by helicopter evacuation (13.3%), was used for those requiring immediate descent. <b><i>Conclusion:</i></b> Altitude illness is a common problem among trekkers in the Annapurna region of Nepal. More effort should be focused on educating high-altitude travelers to reduce the risk of these problems.</p>","PeriodicalId":12975,"journal":{"name":"High altitude medicine & biology","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"High altitude medicine & biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15578682251376256","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0

Abstract

Shrestha, Suraj, Sanjeev Kharel, Suman Acharya, Gobi Basyal, and Sanjeeb S. Bhandari. A Retrospective Analysis of Altitude Illness at the Himalayan Rescue Association Aid Post Manang (2018-2023). High Alt Med Biol. 00:00-00, 2025. Introduction: The Himalayan Rescue Association (HRA) in Nepal has been operating high-altitude aid posts in the Himalayas to alleviate illnesses in hikers and locals with a focus on acute mountain sickness (AMS), high-altitude pulmonary edema (HAPE), and high-altitude cerebral edema (HACE), as well as other common medical problems. This study examines the altitude-related illnesses occurring between 2018 and 2023 at the HRA Manang aid post. Materials and Methods: A retrospective study analyzing the medical records of HRA Manang from 2018 to 2023 was conducted. Demographics and diagnoses were documented, and the Lake Louise Score (LLS) was calculated for AMS cases. The frequency of altitude-related illness was compared among trekkers with/without a good ascent profile. Results: During the study period, a total of 2,904 people visited the aid post, with 337 (11.6%) suffering from altitude-related illnesses, including 274 AMS, 40 HAPE, 11 HACE, and 12 concurrent HAPE with HACE, with 58.8% of cases seen in the fall season. Most were adults, non-Nepali (70.3%), of which only 4.5% comprised the pediatric population. The majority of AMS cases were mild (70.6%) (LLS ≤5), while 17.2% had moderate to severe AMS. Almost one-third (28.2%) of cases had rapid ascent (elevation >500/day above 2,500 m), with a majority of 67.4% being Nepali compared to non-Nepali (p < 0.05). The proportion of HACE and concurrent HAPE with HACE was significantly higher among those with rapid ascent profiles. About 36.20% of cases with altitude-related illness had taken prophylactic acetazolamide, which was considerably lower among Nepali patients (p < 0.001). Motor vehicle evacuation (86.7%), followed by helicopter evacuation (13.3%), was used for those requiring immediate descent. Conclusion: Altitude illness is a common problem among trekkers in the Annapurna region of Nepal. More effort should be focused on educating high-altitude travelers to reduce the risk of these problems.

2018-2023年喜马拉雅救援协会援助站马南高原病回顾性分析
Shrestha, Suraj, Sanjeev Kharel, Suman Acharya, Gobi Basyal和Sanjeeb S. Bhandari。2018-2023年喜马拉雅救援协会援助站马南高原病回顾性分析高Alt医学生物杂志,200,2025。简介:尼泊尔喜马拉雅救援协会(HRA)一直在喜马拉雅地区运营高海拔救援站,以减轻徒步旅行者和当地人的疾病,重点是急性高原病(AMS)、高原肺水肿(HAPE)和高原脑水肿(HACE),以及其他常见的医疗问题。这项研究调查了2018年至2023年期间在HRA Manang援助站发生的与海拔有关的疾病。材料与方法:对2018 - 2023年HRA Manang的病历进行回顾性分析。统计资料和诊断记录,并计算AMS病例的Lake Louise Score (LLS)。比较了具有/不具有良好爬坡特征的徒步旅行者中与海拔有关的疾病的频率。结果:在研究期间,共有2904人访问了救助站,其中337人(11.6%)患有高原相关疾病,其中AMS 274人,HAPE 40人,HACE 11人,HAPE合并HACE 12人,其中秋季发病占58.8%。大多数是成年人,非尼泊尔人(70.3%),其中只有4.5%是儿科人口。以轻度为主(70.6%)(LLS≤5),中度至重度占17.2%。近三分之一(28.2%)的病例快速上升(2500米以上海拔500/天),与非尼泊尔人相比,67.4%的病例为尼泊尔人(p < 0.05)。在快速上升的人群中,HACE和并发HAPE的比例显著高于HACE。约36.20%的高原相关疾病患者曾服用预防性乙酰唑胺,尼泊尔患者的这一比例较低(p < 0.001)。机动车疏散(86.7%),其次是直升机疏散(13.3%),用于需要立即下降的人员。结论:高原病是尼泊尔安纳普尔纳地区徒步旅行者普遍存在的问题。更多的努力应该集中在教育高海拔旅行者减少这些问题的风险上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
High altitude medicine & biology
High altitude medicine & biology 医学-公共卫生、环境卫生与职业卫生
CiteScore
3.80
自引率
9.50%
发文量
44
审稿时长
>12 weeks
期刊介绍: High Altitude Medicine & Biology is the only peer-reviewed journal covering the medical and biological issues that impact human life at high altitudes. The Journal delivers critical findings on the impact of high altitude on lung and heart disease, appetite and weight loss, pulmonary and cerebral edema, hypertension, dehydration, infertility, and other diseases. It covers the full spectrum of high altitude life sciences from pathology to human and animal ecology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信